Sight Sciences Inc
NASDAQ:SGHT

Watchlist Manager
Sight Sciences Inc Logo
Sight Sciences Inc
NASDAQ:SGHT
Watchlist
Price: 8.26 USD 1.35% Market Closed
Market Cap: 436.7m USD

Net Margin
Sight Sciences Inc

-60.6%
Current
-80%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-60.6%
=
Net Income
-46.1m
/
Revenue
76.1m

Net Margin Across Competitors

No Stocks Found

Sight Sciences Inc
Glance View

Market Cap
433.4m USD
Industry
Health Care

Sight Sciences, Inc. is a medical device company, which engages in the provision of glaucoma implants for treatment of irreversible blindness. The company is headquartered in Menlo Park, California and currently employs 212 full-time employees. The company went IPO on 2021-07-15. The firm is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The firm operates through two segments: Surgical Glaucoma and Dry Eye. Its Surgical Glaucoma segment consists of sales of the OMNI surgical system. Its Dry Eye segment includes sales of the TearCare system and related components and accessories. The Company’s Surgical Glaucoma segment has a product portfolio, which features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision. Its Dry Eye segment has a product portfolio, which consists of the TearCare System for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids. The company sells both systems through a direct sales model.

SGHT Intrinsic Value
4.7 USD
Overvaluation 43%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-60.6%
=
Net Income
-46.1m
/
Revenue
76.1m
What is the Net Margin of Sight Sciences Inc?

Based on Sight Sciences Inc's most recent financial statements, the company has Net Margin of -60.6%.

Back to Top